United Immunity, Co., Ltd. announced that it has received ¥800 million in funding from Toho Holdings Co., Ltd., The University of Tokyo Edge Capital Partners Co., Ltd., Saisei Ventures LLC, Venture Labo Investment
September 10, 2023
Share
United Immunity, Co., Ltd. announced that it has raised ¥800 million in an equity round of funding on September 11, 2023. The transaction included participation from new investors, Saisei Bioventures, L.P., managed by Saisei Ventures LLC, UTEC 5 L.P., managed by returning investor, The University of Tokyo Edge Capital Partners Co., Ltd., Toho Holdings Co., Ltd. and returning investor, Ricoh Biomedical Startup Fund, managed by Venture Labo Investment. The company issued shares through third party allocation method.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
United Immunity, Co., Ltd. announced that it has received ¥800 million in funding from Toho Holdings Co., Ltd., The University of Tokyo Edge Capital Partners Co., Ltd., Saisei Ventures LLC, Venture Labo Investment